CervoMed (CRVO) Change in Cash (2010 - 2026)

CervoMed has reported Change in Cash for 17 years, with the latest figure at -$293718.0 in Q1 2026.

• Quarterly Change in Cash fell 119.55% year-over-year to -$293718.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.6 million (down 161.95% YoY) and the FY2025 annual result came in at -$764027.0, down 163.32% from the prior year.
• Change in Cash improved to -$293718.0 in Q1 2026 per CRVO's latest filing, from -$1.2 million in the prior quarter.
• Over five years, Change in Cash peaked at $29.5 million in Q3 2022 and troughed at -$27.4 million in Q1 2022.
• A 5-year average of $75024.3 and a median of -$1.2 million in 2025 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2022 and 2023: Change in Cash surged 1091.33% in 2022, then tumbled 280.03% in 2023.
• Over 5 years, Change in Cash stood at -$692530.0 in 2022, then sank by 280.03% to -$2.6 million in 2023, then surged by 147.72% to $1.3 million in 2024, then plunged by 195.71% to -$1.2 million in 2025, then surged by 75.56% to -$293718.0 in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$293718.0, -$1.2 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.